Concepedia

Kenneth J. Leavitt

KJ

Statistics

Publications

8

Citations

442

H-Index

8

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Bristol-Myers Squibb (Japan)

Kenneth J. Leavitt is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2002–2019

8

Publications

8

Discovery and Preclinical Studies of (<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5- methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor

Rajeev S. Bhide, Zhen‐Wei Cai, Yong‐Zheng Zhang et al. · Journal of Medicinal Chemistry · 2006 · 133 citations · Full text

, , +15

Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)

Soong‐Hoon Kim, Andrew T. Pudzianowski, Kenneth J. Leavitt et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 94 citations · Full text

, , +10

SAR and pH Stability of Cyano-Substituted Epothilones

Alicia Regueiro‐Ren, Kenneth J. Leavitt, Soong‐Hoon Kim et al. · Organic Letters · 2002 · 44 citations

, , +13

New dual inhibitors of EGFR and HER2 protein tyrosine kinases

Brian E. Fink, Gregory D. Vite, Harold Mastalerz et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 44 citations · Full text

, , +14

Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver

Eric S. Muise, Hong-Ping Guan, Jinqi Liu et al. · PLoS ONE · 2019 · 43 citations · Full text

, , +16

1–5 of 8